Cargando…
The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
BACKGROUND: Head and neck cancers are of particular interest to health care providers, their patients, and those paying for health care services, because they have a high morbidity, they are extremely expensive to treat, and of the survivors only 48% return to work. Consequently the economic burden...
Autores principales: | Jacobson, Jed J, Epstein, Joel B, Eichmiller, Frederick C, Gibson, Teresa B, Carls, Ginger S, Vogtmann, Emily, Wang, Shaohung, Murphy, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503554/ https://www.ncbi.nlm.nih.gov/pubmed/22537712 http://dx.doi.org/10.1186/1758-3284-4-15 |
Ejemplares similares
-
Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022) -
Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018) -
Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012) -
Identifying incident oral and pharyngeal cancer cases using Medicare claims
por: Mahnken, Jonathan D, et al.
Publicado: (2013) -
Oral and Pharyngeal Cancer Control and Early Detection
por: Silverman, Sol, et al.
Publicado: (2010)